Enjoy complimentary customisation on priority with our Enterprise License!
The antibiotics market size is estimated to grow at a CAGR of 6.07% between 2022 and 2027. The antibiotics market size is forecast to increase by USD 17,066.66 million. The growth of the market depends on several factors, including the rising prevalence of infectious diseases, the growing awareness of various diseases and their treatment, and special regulatory designations.
This market report extensively covers market segmentation by product (broad-spectrum antibiotics and narrow-spectrum antibiotics), route of administration (intravenous, oral, and others), and geography (Asia, North America, Europe, and Rest of World). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, View Report Sample
The rising prevalence of infectious diseases is notably driving the market growth, although factors such as the development of antibiotic-resistant strains may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of infectious diseases is notably driving the market growth. Globally, there has been an increase in the number of individuals affected by infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases.
Demographic changes caused by increased globalization and urbanization are major factors leading to the global emergence of infectious diseases. Urbanization has led to the overcrowding of human inhabitants. High population densities in these areas favor the colonization of disease pathogens and their persistence in human populations. The expansion of human cities has negatively affected our ecosystems and natural landscapes. For instance, deforestation destroys the natural habitats of animals, which now localize near human habitats. Often these animals are vectors for pathogen transmission, and thus, their movement near human habitats also poses a risk of infection transmission to humans.
The growing number of dams, poor living conditions, lack of sanitation, and inadequate waste management systems are some of the other factors that have increased the incidence and prevalence of diseases. In addition, the changes in environmental conditions and the growing trade and travel are contributing to the increase in the occurrence of infectious diseases among people. Therefore, such factors are estimated to drive the market during the forecast period.
Strategic alliances and mergers and acquisitions (M&A) are major trends in the market. The formation of strategic alliances, in terms of licensing and collaboration, helps in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertise from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company. Such agreements ensure the inflow of adequate funds from both companies and help to reduce liability costs for individual companies in case of failures and attract more venture investments.
M&A is usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Such a deal agreement allows greater exposure of the drug in different regions. Such agreements enable the complete development of the drugs and provide co-development and commercialization rights for the drugs in different regions. One of the examples of M&A that happened in the market is, Bayer acquired Asklepios BioPharmaceutical to broaden the innovation base in cell and gene therapy. Such factors will help the market expansion during the forecast period.
The development of antibiotic-resistant strains is a major challenge impeding the market growth. The development of multidrug-resistant microbes is one of the major threats to human health in the present day. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug.
Antibiotic resistance usually develops due to the irrational use of these drugs. The wrong prescription of the drugs by the physicians or the incorrect dosing or course taken by the individual due to lack of awareness, along with the rampant use of these drugs in livestock, poultry, and other animal husbandry industries, has led to the development of antibiotic-resistant strains of microorganism. This occurs because of the increased accumulation of drugs in the body. The commonly used antibiotic drugs thus become ineffective against the microbes, leading to aggravation of the disease in the body. The development of multidrug-resistant variants is acting as a challenge to the market growth, as the drugs available in the market do not show any efficacy in the treatment of these infections, thus decreasing the acceptance of these substances. This will hamper the focused market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Antibiotics Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company operates under multiple segments including medical devices, and nutritional products with a high focus on medical devices. The company under this segment?offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. The company's key offerings include ACITROM antibiotics.
The antibiotics market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the broad-spectrum antibiotics segment will be significant during the forecast period. Broad-spectrum antibiotics are agents that are effective against a wide range of microorganisms, including Gram-positive and Gram-negative agents.
Get a glance at the market contribution of various segments View PDF Sample
The broad-spectrum antibiotics segment shows a gradual increase in the market share of USD 31,706.25 million in 2017 and continued to grow until 2021. These agents can be used in cases where bacteria do not respond to narrow-spectrum drugs or in cases of serious illness where the infecting agent is not identified, or in cases where multiple bacteria are resulting in the infection. However, the increased use of these agents leads to the development of antibiotic drug resistance. The high market share is attributed to the wide spectrum of activities of these drugs against various microorganisms, making broad-spectrum antibiotics a better option for the treatment of various infections. This can be used as early as the diagnosis or symptoms of any bacterial infection appear before the identification of the disease-causing pathogen. The market is growing due to the rising prevalence of bacterial infections in the sub-economical parts of the underdeveloped and developing regions, where there is improper sanitation, a poor lifestyle of living, and improper disposal of waste, which leads to an increase in bacterial infections, thus increasing the demand for these drugs, thereby driving the market growth.
For more insights on the market share of various regions View PDF Sample now!
Asia is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market in this region is expected to grow rapidly during the forecast period, owing to the increasing demand for improved healthcare infrastructure in this region. In addition, the aging population is expected to play a role in increasing market share. The immune system of the geriatric population is vulnerable, thus making them prone to infections. Therefore, an increase in the aging population, along with the development of healthcare infrastructure, is expected to boost the growth of the market.
The market is expected to grow at a moderate rate due to the increasing healthcare spending in the region. Countries such as China and India are expected to show growth opportunities in the future. This can be attributed to healthcare investments by governments and increasing spending by individuals on healthcare. In addition to this, the irrational use of these chemicals is leading to an increase in the development of drug-resistant bacteria, thereby creating an immense need for the use of broad-spectrum antibiotics. There is a growing awareness among physicians about these drugs, which brings substantial growth opportunities. The transformation of the regulatory landscape in Japan encourages vendors to undertake strategic expansions in the country, thereby driving the market growth.
In 2020, the outbreak of COVID-19 compelled governments of various countries to impose lockdowns in the region for several months. This negatively affected the business and economic activities. However, in 2020, due to large-scale vaccination drives, the regional market in focus resumed with the lifting of lockdown restrictions. Thus, the growth of the regional market is expected to stabilize during the forecast period, with the containment of the COVID-19 pandemic. Also, the growing concern about infectious diseases among people is expected to drive the growth of the market in the region during the forecast period.
The antibiotics market size report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Product (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), Route Of Administration (Intravenous, Oral, and Others), and Geography (Asia, North America, Europe, and Rest of World (ROW)).
Antibiotics Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.07% |
Market growth 2023-2027 |
USD 17,066.66 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.11 |
Regional analysis |
Asia, North America, Europe, and Rest of World (ROW) |
Performing market contribution |
Asia at 41% |
Key countries |
US, UK, China, India, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Get access to Report Sample PDF !
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.